Overview Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial Status: Not yet recruiting Trial end date: 2024-09-01 Target enrollment: Participant gender: Summary Phase II trial of TS23 Phase: Phase 2 Details Lead Sponsor: Translational Sciences, Inc.